The prevalence and features of the polycystic ovary syndrome in an unselected population
- PMID: 15181052
- DOI: 10.1210/jc.2003-032046
The prevalence and features of the polycystic ovary syndrome in an unselected population
Abstract
Notwithstanding the potential public health impact of the polycystic ovary syndrome (PCOS), estimates regarding its prevalence are limited and unclear. Between July 1998 and October 1999, 400 unselected consecutive premenopausal women (18-45 yr of age) seeking a preemployment physical at the University of Alabama at Birmingham were studied (223 Black, 166 White, and 11 of other races). Evaluation included a history and physical examination, a modified Ferriman-Gallwey hirsutism score, and serum screening for hyperandrogenemia, hyperprolactinemia, and 21-hydroxylase-deficient nonclassical adrenal hyperplasia. PCOS was diagnosed by the presence of the following: 1) oligoovulation, 2) hyperandrogenemia and/or hirsutism (modified Ferriman-Gallwey score > or = 6), and 3) the exclusion of related disorders. Confirmed PCOS was established in those individuals whose evaluation was complete and indicative of PCOS, and possible PCOS was established when the hormonal evaluation was not complete or was unavailable, but the clinical phenotype was otherwise suggestive of the disorder. The individual probability of PCOS in women with possible PCOS was assigned a weight based on the findings in similar subjects whose evaluation was complete, and the total number of PCOS cases arising from these individuals was calculated (i.e. individual probability of PCOS x total number of subjects in the group). The cumulative prevalence of PCOS in our population was 6.6% (26.5 of 400), including 15 subjects among the 347 women completing their evaluation and a calculated prevalence of 11.5 subjects among the remainder. The prevalence rates of PCOS for Black and White women were 8.0 and 4.8%, respectively, not significantly different. These data from a large representative unselected population support the concept that PCOS is the most common endocrine abnormality of reproductive-aged women in the United States.
Similar articles
-
Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.J Clin Endocrinol Metab. 1998 Sep;83(9):3078-82. doi: 10.1210/jcem.83.9.5090. J Clin Endocrinol Metab. 1998. PMID: 9745406
-
A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.J Clin Endocrinol Metab. 2000 Jul;85(7):2434-8. doi: 10.1210/jcem.85.7.6682. J Clin Endocrinol Metab. 2000. PMID: 10902790
-
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.Endocr Pract. 2015 Nov;21(11):1291-300. doi: 10.4158/EP15748.DSC. Endocr Pract. 2015. PMID: 26509855
-
Ethnic differences in the phenotypic expression of polycystic ovary syndrome.Steroids. 2013 Aug;78(8):755-60. doi: 10.1016/j.steroids.2013.04.006. Epub 2013 Apr 25. Steroids. 2013. PMID: 23624030 Review.
-
Ethnic differences: Is there an Asian phenotype for polycystic ovarian syndrome?Best Pract Res Clin Obstet Gynaecol. 2016 Nov;37:46-55. doi: 10.1016/j.bpobgyn.2016.04.001. Epub 2016 May 18. Best Pract Res Clin Obstet Gynaecol. 2016. PMID: 27289337 Review.
Cited by
-
The Cardiometabolic Risk in Women with Polycystic Ovarian Syndrome (PCOS): From Pathophysiology to Diagnosis and Treatment.Medicina (Kaunas). 2024 Oct 10;60(10):1656. doi: 10.3390/medicina60101656. Medicina (Kaunas). 2024. PMID: 39459443 Free PMC article. Review.
-
Prevalence, Phenotypes, and Comorbidities of Polycystic Ovary Syndrome Among Indian Women.JAMA Netw Open. 2024 Oct 1;7(10):e2440583. doi: 10.1001/jamanetworkopen.2024.40583. JAMA Netw Open. 2024. PMID: 39441596 Free PMC article.
-
Comparison of self-assessed and clinician-assessed hirsutism diagnosed according to the modified Ferriman-Gallwey scale among female outpatients in Brazil.Arch Endocrinol Metab. 2024 Jun 24;68:e230271. doi: 10.20945/2359-4292-2023-0271. eCollection 2024. Arch Endocrinol Metab. 2024. PMID: 39420908 Free PMC article.
-
The Value of Androgen Measures for Diagnosing Polycystic Ovary Syndrome (PCOS) in an Unselected Population.Reprod Sci. 2024 Oct 17. doi: 10.1007/s43032-024-01702-9. Online ahead of print. Reprod Sci. 2024. PMID: 39419927
-
The role of RAD51 regulators and variants in primary ovarian insufficiency, endometriosis, and polycystic ovary syndrome.NAR Mol Med. 2024 Sep 28;1(4):ugae010. doi: 10.1093/narmme/ugae010. eCollection 2024 Oct. NAR Mol Med. 2024. PMID: 39359934 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
